|
07 December, 2009
|
ICON Announces Details of New Translational Medicine Unit in Manchester
|
|
|
04 December, 2009
|
ICON Receives Warning Letter Relating to Two Studies
|
|
|
02 November, 2009
|
ICON Selected by Lilly to Oversee its Clinical Data Management in Japan
|
|
|
21 October, 2009
|
ICON Reports 14% Increase in EPS, and Raises Earnings Guidance for 2009
|
|
|
23 July, 2009
|
ICON plc: Results of Annual General Meeting
|
|
|
22 July, 2009
|
ICON Reports 22% Increase in EPS and Strong Cash Flows (NASDAQ:ICLR) (ISIN:IE0005711209)
|
|
|
09 July, 2009
|
Letter to Shareholders of ICON plc
|
|
|
09 July, 2009
|
ICON Acquires Veeda Laboratories Limited
|
|
|
26 June, 2009
|
ICON Central Laboratories in Singapore Moves to New Facility to Meet Growing Demand
|
|
|
18 June, 2009
|
New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development
|
|
|
16 June, 2009
|
ICON Announces Collaboration to Develop New Translational Medicine Unit at Purpose-built Hospital Facility in Manchester
|
|
|
09 June, 2009
|
ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
|
|
|
28 April, 2009
|
ICON Reports 9% Increase in Revenue, 25% Increase in EPS and Acquisition of a U.S. Phase I Facility
|
|
|
28 April, 2009
|
ICON Acquires Assets of Qualia Clinical Services, Inc.
|
|
|
24 April, 2009
|
ICON Announces Appointment of Dr. Anthony J. Murphy to the Board of Directors
|
|
|
07 April, 2009
|
ICON Completes CAP Accreditation of its Central Laboratories in Singapore and India
|
|
|
16 March, 2009
|
ICON and MedAvante Sign Alliance Agreement
|
|
|
23 February, 2009
|
ICON reports Full-Year 2008 revenue growth of 37% operating income growth of 44% and EPS growth of 38% (NASDAQ:ICLR) (ISIN:IE0005711209)
|
|
|
26 January, 2009
|
ICON Delivers New Electronic Solution to Expedite Clinical Trial Adjudication
|
|
|
19 January, 2009
|
ICON Recognised as Research Company of the Year at the PharmaTimes Awards
|
|
